
Topical Drugs Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), End-use (Burn Centers, Home Care Settings, Hospitals & Clinics) - Global Forecast 2024-2030
Description
Topical Drugs Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), End-use (Burn Centers, Home Care Settings, Hospitals & Clinics) - Global Forecast 2024-2030
The Topical Drugs Market size was estimated at USD 15.44 billion in 2023 and expected to reach USD 16.86 billion in 2024, at a CAGR 9.64% to reach USD 29.43 billion by 2030.
Global Topical Drugs Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Topical Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Topical Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Topical Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A, Bausch Health Companies Inc., Bayer AG, Cigna Health and Life Insurance Company, Concert Pharmaceuticals, Eli Lilly and Company, GlaxoSmithkline PLC, Hisamitsu Pharmaceuticals Co. Inc., Johnson & Johnson Services, Inc., LEO Pharma A/S, Lupin Limited, Mayne Pharma Group Limited, Mylan N.V., and Tergus Pharma.
Market Segmentation & Coverage
This research report categorizes the Topical Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Liquid Formulations
Solutions
Suspensions
Semi-Solid Formulations
Creams
Gel
Lotions
Ointments
Pastes
Solid Formulations
Powders
Suppositories
Transdermal Products
Transdermal Patches
Transdermal Semi-Solids
End-use
Burn Centers
Home Care Settings
Hospitals & Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Topical Drugs Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Topical Drugs Market?
3. What are the technology trends and regulatory frameworks in the Topical Drugs Market?
4. What is the market share of the leading vendors in the Topical Drugs Market?
5. Which modes and strategic moves are suitable for entering the Topical Drugs Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Topical Drugs Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising incidence of skin disorders, and diabetes
- 5.1.1.2. Increasing demand for self-administered drugs and steroid-free topical medication
- 5.1.1.3. Favorable government approvals for topical drugs
- 5.1.2. Restraints
- 5.1.2.1. Irritations and allergies associated with topical treatments
- 5.1.3. Opportunities
- 5.1.3.1. Innovation in topical drug formulations
- 5.1.3.2. Advancements in drug delivery systems
- 5.1.4. Challenges
- 5.1.4.1. Complex formulations of topical drugs
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Topical Drugs Market, by Product
- 6.1. Introduction
- 6.2. Liquid Formulations
- 6.3.1. Solutions
- 6.3.2. Suspensions
- 6.3. Semi-Solid Formulations
- 6.4.1. Creams
- 6.4.2. Gel
- 6.4.3. Lotions
- 6.4.4. Ointments
- 6.4.5. Pastes
- 6.4. Solid Formulations
- 6.5.1. Powders
- 6.5.2. Suppositories
- 6.5. Transdermal Products
- 6.6.1. Transdermal Patches
- 6.6.2. Transdermal Semi-Solids
- 7. Topical Drugs Market, by End-use
- 7.1. Introduction
- 7.2. Burn Centers
- 7.3. Home Care Settings
- 7.4. Hospitals & Clinics
- 8. Americas Topical Drugs Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Topical Drugs Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Topical Drugs Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. AbbVie Inc.
- 12.1.2. Almirall, S.A
- 12.1.3. Bausch Health Companies Inc.
- 12.1.4. Bayer AG
- 12.1.5. Cigna Health and Life Insurance Company
- 12.1.6. Concert Pharmaceuticals
- 12.1.7. Eli Lilly and Company
- 12.1.8. GlaxoSmithkline PLC
- 12.1.9. Hisamitsu Pharmaceuticals Co. Inc.
- 12.1.10. Johnson & Johnson Services, Inc.
- 12.1.11. LEO Pharma A/S
- 12.1.12. Lupin Limited
- 12.1.13. Mayne Pharma Group Limited
- 12.1.14. Mylan N.V.
- 12.1.15. Tergus Pharma
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. TOPICAL DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. TOPICAL DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. TOPICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. TOPICAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. TOPICAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. TOPICAL DRUGS MARKET DYNAMICS
- FIGURE 7. TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. TOPICAL DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. TOPICAL DRUGS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 10. TOPICAL DRUGS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES TOPICAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. TOPICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. TOPICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.